Karyotype testing is a lab test that produces a visual map of all 46 chromosomes in your cells, arranged by size and shape into 23 pairs. It reveals whether any chromosomes are missing, duplicated, broken, or rearranged. Doctors order it most often during pregnancy, after recurrent miscarriages, or when a child shows signs of a genetic condition.
What a Karyotype Actually Shows
Every human cell (except red blood cells) contains 23 pairs of chromosomes, for a total of 46. Twenty-two of those pairs are numbered 1 through 22 and are called autosomes. The 23rd pair determines biological sex: two X chromosomes in a typical female, one X and one Y in a typical male. A normal female result is written as 46,XX. A normal male result is 46,XY.
To build the karyotype image, a lab technician collects cells, stimulates them to divide, then stains the chromosomes so they show a distinctive banding pattern. Each chromosome has a unique pattern of light and dark bands, almost like a barcode. The technician photographs the chromosomes mid-division, when they’re most visible, then digitally arranges them into matching pairs from largest to smallest. The final image is what your doctor reviews.
This test can detect several categories of problems:
- Extra or missing whole chromosomes. Down syndrome (three copies of chromosome 21), Turner syndrome (a single X with no second sex chromosome), and Klinefelter syndrome (XXY) are classic examples.
- Large structural changes. Pieces of one chromosome may break off and attach to another (translocation), flip orientation within the same chromosome (inversion), or go missing entirely (deletion).
- Mosaicism. Some cells have the normal number of chromosomes while others don’t, producing a mixed result.
What karyotyping cannot do is detect small-scale changes. Single-gene mutations, tiny deletions of just a few genes, or point mutations responsible for conditions like cystic fibrosis or sickle cell disease are too small to see under a microscope. Those require different molecular tests.
Why Doctors Order It
The most common reason is prenatal screening. If an earlier blood test or ultrasound suggests a higher chance of a chromosomal condition, karyotyping on fetal cells can confirm or rule it out. Fetal cells are collected through amniocentesis (drawing a small amount of amniotic fluid, typically between weeks 15 and 20) or chorionic villus sampling, known as CVS (taking a tiny tissue sample from the placenta, usually between weeks 10 and 13).
Outside of pregnancy, karyotyping is commonly ordered for couples who have experienced two or more miscarriages. Roughly 2 to 5 percent of couples with recurrent pregnancy loss carry a balanced translocation, meaning pieces of two chromosomes have swapped places. The carrier is healthy because no genetic material is actually missing, but when their cells divide to form eggs or sperm, the rearranged chromosomes can produce embryos with unbalanced genetic material that cannot survive.
Pediatricians may request a karyotype when a child has unexplained developmental delays, unusual physical features, ambiguous genitalia, or very short stature. In adults, the test sometimes plays a role in diagnosing certain blood cancers. Chronic myeloid leukemia, for instance, is linked to a specific translocation between chromosomes 9 and 22 that creates what’s called the Philadelphia chromosome. Identifying it helps guide treatment decisions.
How the Test Works Step by Step
For most people, the process starts with a simple blood draw. White blood cells are the target because, unlike red blood cells, they contain a nucleus with a full set of chromosomes. The lab adds a chemical that stimulates the white blood cells to divide, then after a couple of days, applies another chemical to freeze the cells in the middle of division. At this stage, the chromosomes are tightly coiled and easiest to photograph.
The cells are then placed on a glass slide, treated with a stain (Giemsa stain is standard), and examined under a high-powered microscope. A technician typically analyzes 20 or more cells to check for consistency. If some cells look different from others, additional cells are counted to determine whether mosaicism is present.
For prenatal karyotyping, the sample comes from amniotic fluid or placental tissue rather than blood. The fetal cells in these samples often need to be cultured (grown in a lab dish) for 7 to 14 days before there are enough dividing cells to analyze. This culturing step is why prenatal karyotype results take longer than many parents expect.
How Long Results Take
Blood karyotypes for children or adults generally come back within 1 to 3 weeks. Prenatal results from amniocentesis or CVS typically take 10 to 14 days because of the extra cell-culturing time. Some labs offer a rapid preliminary screen called FISH (fluorescence in situ hybridization) that checks for the most common chromosomal conditions within 24 to 48 hours, but a full karyotype still follows to confirm and provide the complete picture.
Bone marrow karyotypes, ordered for blood cancers, can sometimes return faster because bone marrow cells divide rapidly on their own and don’t need as much time in culture.
Understanding Your Results
A normal result will simply read 46,XX or 46,XY with no additional notations. Any variation from that gets described using a standardized shorthand. For example, 47,XX,+21 means a female with three copies of chromosome 21, which is Down syndrome. 45,X means only one sex chromosome is present, indicating Turner syndrome.
Structural changes are noted with abbreviations: “t” for translocation, “del” for deletion, “inv” for inversion, followed by the chromosome numbers involved. Your geneticist or genetic counselor will walk through the specific notation and explain what it means for you or your child in practical terms.
One result that often causes confusion is a balanced translocation or inversion in a healthy adult. Because no genetic material is gained or lost, the person typically has no symptoms at all. The finding matters mainly for family planning, since it increases the chance of producing eggs or sperm with unbalanced chromosomes, which can lead to miscarriage or a child with a genetic condition. Genetic counseling can help you understand the specific reproductive risks based on which chromosomes are involved.
Karyotyping vs. Newer Genetic Tests
Karyotyping has been in clinical use since the 1960s and remains the gold standard for detecting whole-chromosome gains, losses, and large rearrangements. But it has a resolution limit: changes smaller than about 5 to 10 million base pairs of DNA are generally too small to see under the microscope.
Chromosomal microarray analysis (CMA) can detect much smaller deletions and duplications, down to roughly 50,000 to 100,000 base pairs. Many genetics labs now use microarray as a first-line test for children with developmental delays or intellectual disability because it catches submicroscopic changes that karyotyping misses. However, microarray cannot detect balanced translocations or inversions because no material is gained or lost. That’s where karyotyping still has an advantage.
Non-invasive prenatal testing (NIPT), the blood draw offered to pregnant people as early as 10 weeks, screens for common chromosomal conditions by analyzing fragments of fetal DNA circulating in the mother’s blood. It’s a screening tool, not a diagnostic one. A positive NIPT result still needs confirmation through amniocentesis or CVS with a full karyotype. The two tests answer different questions: NIPT estimates probability, while karyotyping provides a definitive answer.
Risks and Limitations
A blood draw for karyotyping carries no meaningful risk beyond minor bruising. The risk comes with prenatal sampling. Amniocentesis carries a small chance of miscarriage, generally estimated at about 1 in 300 to 1 in 500 procedures. CVS has a similar risk profile. These numbers have improved over the decades as ultrasound guidance has become standard.
The main limitation of the test itself is what it can’t see. Small genetic changes, single-gene disorders, and epigenetic conditions are invisible on a karyotype. A normal result rules out major chromosomal problems but doesn’t guarantee the absence of all genetic conditions. If a karyotype comes back normal but symptoms remain unexplained, your doctor may recommend additional molecular testing to look at a finer level of detail.